Tag Archives: Featuring

Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

Severe Asthma Digital Marketing Trends Report 2022 Featuring Sanofi, Regeneron, Genentech, Novartis, GSK, AstraZeneca, Amgen, & Teva

DUBLIN, Nov. 21, 2022 /PRNewswire/ — The “Digital Marketing Trends in Severe Asthma” report has been added to ResearchAndMarkets.com’s offering. Research and Markets Logo Sanofi/Regeneron’s Dupixent.com achieved the highest traffic across branded severe asthma patient sites in the US from July 2021 to June 2022, with about 7,800,000 visits, followed by Novartis’ Xolair.com, and GSK’s Nucala.com. The highest proportion of traffic to these sites originated from direct sources, followed by… Source link

Read More »

Digital Summit Series Returns to Philadelphia Featuring Actionable Marketing Insights from Spotify, LinkedIn, Crayola, SiriusXM, Deloitte and More

Digital Summit Series Returns to Philadelphia Featuring Actionable Marketing Insights from Spotify, LinkedIn, Crayola, SiriusXM, Deloitte and More

Taking place on May 23-24 in Philadelphia’s bustling Center City neighborhood, Digital Summit Philadelphia 2022 will feature 30+ sessions presented by national brands and local experts that unlock practical insights and breakthrough strategies for marketing professionals PHILADELPHIA, May 5, 2022 /PRNewswire-PRWeb/ — Digital Summit Philadelphia will be held on Mon., May 23, 2022 – Tues., May 24, 2022, at the Philadelphia Marriott Downtown in Philadelphia, PA. The two-day, in-person… Source link

Read More »

Digital Marketing Trends in Rheumatoid Arthritis, 2022 Research Report Featuring AbbVie, Janssen, Eli Lilly, Amgen, UCB, Pfizer, Roche, Sanofi, & Regeneron

Digital Marketing Trends in Rheumatoid Arthritis, 2022 Research Report Featuring AbbVie, Janssen, Eli Lilly, Amgen, UCB, Pfizer, Roche, Sanofi, & Regeneron

DUBLIN, May 05, 2022–(BUSINESS WIRE)–The “Digital Marketing Trends in Rheumatoid Arthritis” report has been added to ResearchAndMarkets.com’s offering. AbbVie’s Humira.com achieved the highest total traffic across RA patient sites in the US, with 7.3 million visitors from February 2021 to January 2022, followed by Pfizer’s Xeljanz.com and Amgen’s Enbrel.com. The highest proportion of traffic to branded patient RA websites originated from direct sources, followed by paid. Remicade.com and… Source link

Read More »